SpaceX shares surged over 14% Tuesday, briefly surpassing Amazon and challenging Microsoft with a nearly $2.9 trillion valuation. The rally...

Real estate stocks have surged nearly 9% in three days, with some analysts citing attractive valuations after a prolonged correction. This ...

Foreign institutional investors have sold Indian stocks worth Rs 5.5 lakh crore. However, a hidden list reveals 84 stocks where FIIs have a...

Cyient’s Rs 720 crore share buyback enters the final stage, with June 16 as the last date to buy shares to qualify. The record date is June...

The talks were ongoing and the price could change, or the discussions could fall apart, according to the report. It was not clear if the pr...

Improved investor sentiment following the interim US-Iran peace agreement has supported equities as crude fell below $85, easing inflation ...

Indian markets are surging out of a month-long lull, with Nifty poised to reclaim April highs. Rajesh Bhosale of Angel One sees strong posi...

Stock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...

Vedanta’s four demerged entities debuted on exchanges, with brokerages highlighting aluminium as the most attractive segment. Analysts cite...

Brokerages remain selective on India's energy sector, favouring companies with strong growth drivers and attractive valuations. Morgan Stan...

Stock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...

Nifty's strong breakout above 23,500 has turned technical analysts bullish, anticipating a move towards 24,000-24,500. Analysts highlight i...

Nestle India Ltd has broken out of a falling channel resistance on daily charts, signaling potential for further gains. Experts suggest sho...

On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...

Domestic markets recovered modestly on easing oil prices and selective buying in banking and pharma stocks. Analysts have recommended Allie...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

Jefferies sees significant growth for Meesho. The brokerage initiated coverage with a 'Buy' rating and a target price of Rs 225. This sugge...